awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34173071-A8AB3FF8-01EC-4C9B-967A-0FFDB7D3667F
Q34173071-A8AB3FF8-01EC-4C9B-967A-0FFDB7D3667F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34173071-A8AB3FF8-01EC-4C9B-967A-0FFDB7D3667F
A review of the history, properties, and use of the immunomodulatory compound lenalidomide.
P2860
Q34173071-A8AB3FF8-01EC-4C9B-967A-0FFDB7D3667F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34173071-A8AB3FF8-01EC-4C9B-967A-0FFDB7D3667F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bd5d7305eb62e3ee6a8974980fe44dbe58dd028d
P2860
Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro.